Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 6, 2021

A conspicuous reduced plasma creatinine: the first presenting sign of Waldenstrom macroglobulinemia

Wilma Potze EMAIL logo , Michel J. Vos , Henk Engel and Joan Doornebal

Corresponding author: Wilma Potze, MD, PhD, Department of Nephrology, Isala Clinics, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands, Phone: +31 633889362, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Not applicable.

References

1. Greenberg, N, Roberts, WL, Bachmann, LM, Wright, EC, Dalton, RN, Zakowski, JJ, et al.. Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem 2012;58:391–401. https://doi.org/10.1373/clinchem.2011.172288.Search in Google Scholar

2. Metraiah, EH, Regan, H, Louw, J, Kidder, D. Deceiving proteins! A case of lymphoma and high creatinine. BMJ Case Rep 2017;bcr2016217946. https://doi.org/10.1136/bcr-2016-217946.Search in Google Scholar

3. McGill, MR, Vijayan, A, Trulock, EP, Wit, CA, Kohler, GD, Scott, MG. Falsely elevated plasma creatinine due to an immunoglobulin M paraprotein. Am J Kidney Dis 2016;68:789–92. https://doi.org/10.1053/j.ajkd.2016.05.014.Search in Google Scholar

4. Hummel, KM, von Ahsen, N, Kühn, RB, Kaboth, U, Grunwald, RW, Oellerich, M, et al.. Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström’s macroglobulinemia. Nephron 2000;86:188–9. https://doi.org/10.1159/000045741.Search in Google Scholar

5. Rudofsky, G, Villalobos, M, Waldherr, R, Schaier, M, Zorn, M, Maimer, A, et al.. The case: renal failure in a male with Waldenström’s macroglobulinemia. Kidney Int 2010;77:371–2. https://doi.org/10.1038/ki.2009.465.Search in Google Scholar

6. Bakker, AJ, Mücke, M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med 2007;45:1240–3. https://doi.org/10.1515/CCLM.2007.254.Search in Google Scholar

7. Smogorzewska, A, Flood, JG, Long, WH, Dighe, AS. Paraprotein interference in automated chemistry analyzers. Clin Chem 2004;50:1691–3. https://doi.org/10.1373/clinchem.2004.037499.Search in Google Scholar

Received: 2021-06-28
Accepted: 2021-08-29
Published Online: 2021-09-06
Published in Print: 2022-01-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 9.12.2022 from https://www.degruyter.com/document/doi/10.1515/cclm-2021-0742/html
Scroll Up Arrow